Ruth Scherz-Shouval
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ruth Scherz-Shouval has a total of 356 co-authors. Here are the top co-authors by number of shared publications:
- Shimrit Mayer
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
43 shared publications - Coral Halperin
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
41 shared publications - Yaniv Stein
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
41 shared publications - Oshrat Levi-Galibov
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
37 shared publications - Aviad Ben-Shmuel
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
25 shared publications - Maya Dadiani
Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel
24 shared publications
Latest Publications
- Open Access
TCF21 loss identifies a conserved inflammation-associated fibroblast state across Crohn’s disease and ulcerative colitis
Background and Aims: Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are associated with stromal remodeling; however, the fibroblast states that contribute to chronic inflammation remain incompletely defined. We aimed to identify conserved pathogenic fibroblast programs across CD and UC and determine whether these states are linked to loss of homeostatic stromal regulators. Methods: We integrated publicly available single-cell RNA sequencing datasets from healthy and inflamed intestinal tissues to define stromal populations across CD, UC, and control samples. Fibroblast subsets were annotated using cluster-specific markers and patient-level abundance analyses. Multiplex immunofluorescence of human gastrointestinal tissue microarrays assessed protein expression. Human colonic fibroblasts were stimulated with IL1B and TNF to model inflammation-associated fibroblast polarization, and restoration of homeostatic factors was evaluated using mRNA-loaded lipid nanoparticles (LNPs). Results: A conserved inflammation-associated fibroblast (IAF) population was expanded in both CD and UC and expressed inflammatory chemokines, matrix-remodeling genes, and activation markers including CXCL1 , MMP3 , FAP , and PDPN . In contrast, a homeostatic ADAMDEC1 / TCF21 -enriched fibroblast population was reduced in inflamed tissue. TCF21 expression positively correlated with ADAMDEC1 and negatively correlated with activation markers. Multiplex immunofluorescence confirmed depletion of TCF21-positive non-immune, stromal cells in IBD tissue. In vitro , IL1B and TNF induced an IAF-like phenotype and reduced TCF21 . TCF21 mRNA-LNP restoration attenuated inflammatory mediators including IL1B and IL6 . Conclusions: TCF21 loss identifies a conserved inflammation-associated fibroblast state across CD and UC. Restoring TCF21 partially suppresses inflammatory fibroblast programs, supporting stromal reprogramming as a therapeutic concept in IBD.
Open AccessTCF21 loss identifies a conserved inflammation-associated fibroblast state across Crohn’s disease and ulcerative colitis
Background and Aims: Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are associated with stromal remodeling; however, the fibroblast states that contribute to chronic inflammation remain incompletely defined. We aimed to identify conserved pathogenic fibroblast programs across CD and UC and determine whether these states are linked to loss of homeostatic stromal regulators. Methods: We integrated publicly available single-cell RNA sequencing datasets from healthy and inflamed intestinal tissues to define stromal populations across CD, UC, and control samples. Fibroblast subsets were annotated using cluster-specific markers and patient-level abundance analyses. Multiplex immunofluorescence of human gastrointestinal tissue microarrays assessed protein expression. Human colonic fibroblasts were stimulated with IL1B and TNF to model inflammation-associated fibroblast polarization, and restoration of homeostatic factors was evaluated using mRNA-loaded lipid nanoparticles (LNPs). Results: A conserved inflammation-associated fibroblast (IAF) population was expanded in both CD and UC and expressed inflammatory chemokines, matrix-remodeling genes, and activation markers including CXCL1 , MMP3 , FAP , and PDPN . In contrast, a homeostatic ADAMDEC1 / TCF21 -enriched fibroblast population was reduced in inflamed tissue. TCF21 expression positively correlated with ADAMDEC1 and negatively correlated with activation markers. Multiplex immunofluorescence confirmed depletion of TCF21-positive non-immune, stromal cells in IBD tissue. In vitro , IL1B and TNF induced an IAF-like phenotype and reduced TCF21 . TCF21 mRNA-LNP restoration attenuated inflammatory mediators including IL1B and IL6 . Conclusions: TCF21 loss identifies a conserved inflammation-associated fibroblast state across CD and UC. Restoring TCF21 partially suppresses inflammatory fibroblast programs, supporting stromal reprogramming as a therapeutic concept in IBD.
- Open Access
Persistent stromal reprogramming defines incomplete mucosal healing and predicts therapeutic response in ulcerative colitis
Mucosal healing (MH) is the primary therapeutic endpoint in ulcerative colitis (UC), yet frequent relapses suggest it does not reflect complete tissue recovery. To define the basis of this vulnerability, we generated a multimodal atlas of UC integrating single-cell and bulk transcriptomics, Visium HD spatial profiling, and multiplexed imaging across 89 patients. We show that MH represents a distinct biological state marked by persistent stromal remodeling along three axes: emergence of inflammatory fibroblasts, sustained loss of OGN⁺ niche-supporting fibroblasts, and expansion of pericytes with matrix-remodeling features and reduced vascular association. Spatial analyses revealed persistent reorganization of mucosal tissue domains despite apparent clinical remission. Across independent cohorts, baseline inflammatory fibroblast and pericyte signatures robustly predicted non-response to anti-TNF therapy. These findings suggest that patients in MH remain in a biologically altered state linked to relapse risk and identify stromal reprogramming as a determinant of disease persistence and therapeutic response in UC.
Open AccessPersistent stromal reprogramming defines incomplete mucosal healing and predicts therapeutic response in ulcerative colitis
Mucosal healing (MH) is the primary therapeutic endpoint in ulcerative colitis (UC), yet frequent relapses suggest it does not reflect complete tissue recovery. To define the basis of this vulnerability, we generated a multimodal atlas of UC integrating single-cell and bulk transcriptomics, Visium HD spatial profiling, and multiplexed imaging across 89 patients. We show that MH represents a distinct biological state marked by persistent stromal remodeling along three axes: emergence of inflammatory fibroblasts, sustained loss of OGN⁺ niche-supporting fibroblasts, and expansion of pericytes with matrix-remodeling features and reduced vascular association. Spatial analyses revealed persistent reorganization of mucosal tissue domains despite apparent clinical remission. Across independent cohorts, baseline inflammatory fibroblast and pericyte signatures robustly predicted non-response to anti-TNF therapy. These findings suggest that patients in MH remain in a biologically altered state linked to relapse risk and identify stromal reprogramming as a determinant of disease persistence and therapeutic response in UC.
- Top Cited Papers
- 20 April 2026
- Published by Springer Nature in Nature Cancer
Heterogeneity and plasticity of cancer-associated fibroblasts
Fibroblasts sense and respond to contextual cues to support tissue structure and function. In cancer, they engage a dysregulated wound-healing response that profoundly shapes tumor composition and progression. Efforts to therapeutically target these cancer-associated fibroblasts (CAFs) have been complicated by their heterogeneity and plasticity. However, recent advances, particularly in single-cell and spatial technologies, have greatly improved the understanding of the phenotypic consequences of distinct CAF states and functions. Here we review the current understanding of CAFs as heterogeneous, instructive regulators of tumor microenvironments across anatomic sites and highlight key challenges for the future.
- 20 April 2026
- Published by Springer Nature in Nature Cancer
Top Cited PapersHeterogeneity and plasticity of cancer-associated fibroblasts
Fibroblasts sense and respond to contextual cues to support tissue structure and function. In cancer, they engage a dysregulated wound-healing response that profoundly shapes tumor composition and progression. Efforts to therapeutically target these cancer-associated fibroblasts (CAFs) have been complicated by their heterogeneity and plasticity. However, recent advances, particularly in single-cell and spatial technologies, have greatly improved the understanding of the phenotypic consequences of distinct CAF states and functions. Here we review the current understanding of CAFs as heterogeneous, instructive regulators of tumor microenvironments across anatomic sites and highlight key challenges for the future.
- Open Access
The U-method: Leveraging expression probability for robust biological marker detection
Reliable identification of cluster-defining markers is fundamental to single-cell transcriptomic analysis, yet current approaches often rely on average expression differences, which can dilute biologically informative signals in sparse and heterogeneous data. Here we introduce the U-method, a fast probability-based framework for identifying uniquely expressed genes (UEGs) by contrasting a gene’s expression probability within a cluster with its highest expression probability in any other cluster. This highest-probability comparison prioritizes detection consistency over expression magnitude, resulting in markers that consistently identify cell populations across independent datasets analyzed at comparable clustering resolutions. Applied to colorectal, breast, pancreatic, and lung cancer single-cell RNA-sequencing datasets, the U-method identifies canonical lineage markers together with additional genes showing clear cluster specificity. When projected onto Visium HD spatial transcriptomics data using only raw average expression of top UEGs, these signatures reveal coherent and biologically interpretable tissue organization without the need for smoothing, deconvolution, or model-based spatial inference. These results position the U-method as a practical implementation of detection consistency, enabling robust marker discovery and spatial interpretation in single-cell analysis.
Open AccessThe U-method: Leveraging expression probability for robust biological marker detection
Reliable identification of cluster-defining markers is fundamental to single-cell transcriptomic analysis, yet current approaches often rely on average expression differences, which can dilute biologically informative signals in sparse and heterogeneous data. Here we introduce the U-method, a fast probability-based framework for identifying uniquely expressed genes (UEGs) by contrasting a gene’s expression probability within a cluster with its highest expression probability in any other cluster. This highest-probability comparison prioritizes detection consistency over expression magnitude, resulting in markers that consistently identify cell populations across independent datasets analyzed at comparable clustering resolutions. Applied to colorectal, breast, pancreatic, and lung cancer single-cell RNA-sequencing datasets, the U-method identifies canonical lineage markers together with additional genes showing clear cluster specificity. When projected onto Visium HD spatial transcriptomics data using only raw average expression of top UEGs, these signatures reveal coherent and biologically interpretable tissue organization without the need for smoothing, deconvolution, or model-based spatial inference. These results position the U-method as a practical implementation of detection consistency, enabling robust marker discovery and spatial interpretation in single-cell analysis.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure 7 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
LOX inhibition reduces metastasis in chemotherapy-treated mice. A and B, Tumor-free, 8- to 10-week-old BALB/c mice were treated with PTX or vehicle control. After 72 hours, blood was obtained and plasma was separated. The plasma was either left unprocessed or depleted of LOX using neutralizing antibodies. Plasma (100 μL/mouse) was injected intraperitoneally into naïve BALB/c mice (n = 4–5 mice/group), and after 72 hours, lungs were removed and assessed for collagen and elastin content by Sirius red staining. Representative images in two magnifications are shown in A. Arrows, positive staining. Scale bar, 200 μm. Collagen and elastin levels were quantified (B) by calculating the percentage of red pixels per total lung area (n > 4 fields/lung). C and D, Collagen-coated plates were incubated with plasma from mice described in A and B for 4 hours and then washed. EMT6 cells (2 × 104 cells/well) were then seeded onto the plates, and after 15 minutes, nonadherent cells were removed. Adherent cells were stained with DAPI and analyzed by fluorescence microscopy. Representative images are shown in C. Scale bar, 50 μm. Quantification of adherent cells is shown in D. E and F, Tumor-free BALB/c mice were treated with vehicle control or PTX in the presence or absence of BAPN or anti-LOX antibodies. After 3 days, EMT6-GFP+ cells (25 × 104 cells) were injected through the tail vein for the ex vivo PuMA. After 15 minutes, lungs were perfused, excised, and sectioned. Lung sections were cultured for 1 week and analyzed by FluorVivo Mag system. Representative images are shown in E. Metastatic foci (green) are indicated by arrows. Scale bar, 200 μm. The percentage of GFP+ cells in single-cell suspensions of lung sections was analyzed by flow cytometry (F). G and H, BALB/c mice were implanted with EMT6-F2 cells in the mammary fat pad (n = 5 mice/group). When tumors reached 250 mm3, mice were treated with vehicle control, PTX, BAPN, or a combination of PTX and BAPN. When tumors in control mice reached 1,000 mm3, mice were sacrificed and lungs were analyzed for metastasis by H&E staining. G, Representative images are shown in two magnifications. Arrows, metastatic foci. Scale bar, 200 μm. H, Lung metastases were quantified per field (n > 4 fields/lung). Statistical significance was assessed by one-way ANOVA followed by Tukey posttest when more than two groups were analyzed or unpaired two-tailed t test when only two groups were analyzed. Significant P values are shown as *, P < 0.05; **, P < 0.01; ***, P < 0.001 from control or otherwise indicated in the figure.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 7 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
LOX inhibition reduces metastasis in chemotherapy-treated mice. A and B, Tumor-free, 8- to 10-week-old BALB/c mice were treated with PTX or vehicle control. After 72 hours, blood was obtained and plasma was separated. The plasma was either left unprocessed or depleted of LOX using neutralizing antibodies. Plasma (100 μL/mouse) was injected intraperitoneally into naïve BALB/c mice (n = 4–5 mice/group), and after 72 hours, lungs were removed and assessed for collagen and elastin content by Sirius red staining. Representative images in two magnifications are shown in A. Arrows, positive staining. Scale bar, 200 μm. Collagen and elastin levels were quantified (B) by calculating the percentage of red pixels per total lung area (n > 4 fields/lung). C and D, Collagen-coated plates were incubated with plasma from mice described in A and B for 4 hours and then washed. EMT6 cells (2 × 104 cells/well) were then seeded onto the plates, and after 15 minutes, nonadherent cells were removed. Adherent cells were stained with DAPI and analyzed by fluorescence microscopy. Representative images are shown in C. Scale bar, 50 μm. Quantification of adherent cells is shown in D. E and F, Tumor-free BALB/c mice were treated with vehicle control or PTX in the presence or absence of BAPN or anti-LOX antibodies. After 3 days, EMT6-GFP+ cells (25 × 104 cells) were injected through the tail vein for the ex vivo PuMA. After 15 minutes, lungs were perfused, excised, and sectioned. Lung sections were cultured for 1 week and analyzed by FluorVivo Mag system. Representative images are shown in E. Metastatic foci (green) are indicated by arrows. Scale bar, 200 μm. The percentage of GFP+ cells in single-cell suspensions of lung sections was analyzed by flow cytometry (F). G and H, BALB/c mice were implanted with EMT6-F2 cells in the mammary fat pad (n = 5 mice/group). When tumors reached 250 mm3, mice were treated with vehicle control, PTX, BAPN, or a combination of PTX and BAPN. When tumors in control mice reached 1,000 mm3, mice were sacrificed and lungs were analyzed for metastasis by H&E staining. G, Representative images are shown in two magnifications. Arrows, metastatic foci. Scale bar, 200 μm. H, Lung metastases were quantified per field (n > 4 fields/lung). Statistical significance was assessed by one-way ANOVA followed by Tukey posttest when more than two groups were analyzed or unpaired two-tailed t test when only two groups were analyzed. Significant P values are shown as *, P < 0.05; **, P < 0.01; ***, P < 0.001 from control or otherwise indicated in the figure.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure 1 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
Chemotherapy induces pulmonary ECM remodeling. Tumor-free, 8- to 10-week-old BALB/c mice were treated with PTX or vehicle (control). After 72 hours, mice were sacrificed and lungs were removed. Lungs were formalin-fixed and subsequently sectioned (n = 5 mice/group). A, Lung sections were immunostained with antibodies against collagen I, collagen IV, laminin, and fibronectin (shown in brown) and counterstained with hematoxylin. Representative images in two magnifications are shown. Scale bar, 200 μm. B, The percentage of positive pixels per total lung area was quantified. C, Lung sections were stained with Sirius red to detect collagen and elastin (red). Representative images in two magnifications are shown. Arrows indicate collagen and elastin staining. Collagen and elastin levels were quantified by calculating the percentage of red pixels per total lung area. Scale bar, 200 μm. D, Lung cryo-sections from the control and 72 hours after PTX therapy (PTX) were imaged by 2-photon microscopy. Top, representative SHG images are shown. Fibrillar collagen structure is designated in red. Scale bar, 50 μm. Bottom, the percentage of red pixels was quantified (n > 4 fields/lung). E and F, In a parallel experiment, protein lysates from lungs obtained from mice 72 hours after treatment with vehicle control or PTX (n = 5 mice/group) were analyzed for the expression of the indicated ECM components by Western blot, followed by densitometry analysis (E) or for newly synthesized collagen, using Sircol collagen assay kit (F). Statistical significance was assessed by unpaired two-tailed t test. Significant P values are shown as *, P < 0.05; **, P < 0.01; ***, P < 0.001 from control.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 1 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
Chemotherapy induces pulmonary ECM remodeling. Tumor-free, 8- to 10-week-old BALB/c mice were treated with PTX or vehicle (control). After 72 hours, mice were sacrificed and lungs were removed. Lungs were formalin-fixed and subsequently sectioned (n = 5 mice/group). A, Lung sections were immunostained with antibodies against collagen I, collagen IV, laminin, and fibronectin (shown in brown) and counterstained with hematoxylin. Representative images in two magnifications are shown. Scale bar, 200 μm. B, The percentage of positive pixels per total lung area was quantified. C, Lung sections were stained with Sirius red to detect collagen and elastin (red). Representative images in two magnifications are shown. Arrows indicate collagen and elastin staining. Collagen and elastin levels were quantified by calculating the percentage of red pixels per total lung area. Scale bar, 200 μm. D, Lung cryo-sections from the control and 72 hours after PTX therapy (PTX) were imaged by 2-photon microscopy. Top, representative SHG images are shown. Fibrillar collagen structure is designated in red. Scale bar, 50 μm. Bottom, the percentage of red pixels was quantified (n > 4 fields/lung). E and F, In a parallel experiment, protein lysates from lungs obtained from mice 72 hours after treatment with vehicle control or PTX (n = 5 mice/group) were analyzed for the expression of the indicated ECM components by Western blot, followed by densitometry analysis (E) or for newly synthesized collagen, using Sircol collagen assay kit (F). Statistical significance was assessed by unpaired two-tailed t test. Significant P values are shown as *, P < 0.05; **, P < 0.01; ***, P < 0.001 from control.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
Supplemental materials and methods and supplemental figures
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
Supplemental materials and methods and supplemental figures
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure 4 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
Plasma from PTX-treated mice promotes pulmonary ECM remodeling. Tumor-free, 8- to 10-week-old BALB/c mice were treated with PTX or vehicle control. After 24 hours, blood was obtained by cardiac puncture and plasma was separated. The plasma was then injected intraperitoneally to naïve BALB/c mice (100 μL/mouse), and 72 hours later, lungs were removed (n = 4 mice/group). A, Lungs were analyzed for collagen content by Masson's trichrome staining. Representative images are shown with quantification of collagen staining per field (n > 4 fields/lung). Scale bar, 50 μm. B, The levels of collagen I, collagen IV, and LOX in lung sections were analyzed by immunostaining (red). Nuclei were stained with DAPI (blue). Scale bar, 50 μm. The percentage of red pixels per field was quantified (n > 4 fields/lung). C, Lung sections were also immunostained with antibodies against Collagen I and IV (shown in brown), and counterstained with hematoxylin. Representative images in two magnifications are shown. Scale bar, 200 μm. D, In a parallel experiment, collagen-coated plates were pretreated with plasma (10%) from control or PTX-treated mice for 4 hours, followed by washing. EMT6 cells (2 × 104 cells/well) were then seeded onto the plates, and after 15 minutes, nonadherent cells were removed. Adherent cells were stained with DAPI and analyzed by fluorescence microscopy. Representative images are shown on the left. Scale bar, 75 μm. Quantification of adherent cells is shown on the right. Statistical significance was assessed by unpaired two-tailed t test. Significant P values are shown as *, P < 0.05; **, P < 0.01; ***, P < 0.001.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 4 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
Plasma from PTX-treated mice promotes pulmonary ECM remodeling. Tumor-free, 8- to 10-week-old BALB/c mice were treated with PTX or vehicle control. After 24 hours, blood was obtained by cardiac puncture and plasma was separated. The plasma was then injected intraperitoneally to naïve BALB/c mice (100 μL/mouse), and 72 hours later, lungs were removed (n = 4 mice/group). A, Lungs were analyzed for collagen content by Masson's trichrome staining. Representative images are shown with quantification of collagen staining per field (n > 4 fields/lung). Scale bar, 50 μm. B, The levels of collagen I, collagen IV, and LOX in lung sections were analyzed by immunostaining (red). Nuclei were stained with DAPI (blue). Scale bar, 50 μm. The percentage of red pixels per field was quantified (n > 4 fields/lung). C, Lung sections were also immunostained with antibodies against Collagen I and IV (shown in brown), and counterstained with hematoxylin. Representative images in two magnifications are shown. Scale bar, 200 μm. D, In a parallel experiment, collagen-coated plates were pretreated with plasma (10%) from control or PTX-treated mice for 4 hours, followed by washing. EMT6 cells (2 × 104 cells/well) were then seeded onto the plates, and after 15 minutes, nonadherent cells were removed. Adherent cells were stained with DAPI and analyzed by fluorescence microscopy. Representative images are shown on the left. Scale bar, 75 μm. Quantification of adherent cells is shown on the right. Statistical significance was assessed by unpaired two-tailed t test. Significant P values are shown as *, P < 0.05; **, P < 0.01; ***, P < 0.001.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure 5 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
Systemic LOX promotes ECM remodeling following PTX chemotherapy. Bone marrow cells were flushed from Cre+/−LOXflox/flox or their control counterpart Cre−/−LOXflox/flox mice. The bone marrow cells were then implanted into lethally irradiated wild-type BALB/c mice to generate a chimeric mouse model of inducible LOX depletion specifically in bone marrow cells. The chimeric mice (n = 6 mice/group) were treated with tamoxifen for 5 days, and PTX was administered on day 7. After 72 hours, mice were sacrificed and lungs and bone marrow were harvested. A, A schematic of the experimental procedure is presented. LOX levels in bone marrow cells were assessed by Western blot. B, Lung sections were stained with Sirius red to detect both collagen and elastin. Representative images are shown in two magnifications. Arrows, positive staining. Scale bar, 200 μm. Collagen and elastin levels were quantified by calculating the percentage of red pixels per field (n > 4 fields/lung). C–G, Tumor-free, 8- to 10-week-old SCID mice (n = 4–5 mice/group) were treated with PTX or vehicle control. After 72 hours, lungs were removed. Collagen and elastin in lung sections were detected by Sirius staining. Representative images in two magnifications are shown in C (scale bar, 200 μm), and quantification is shown in D. Lung sections were immunostained using antibodies against Collagen I (E), Collagen IV (F), and LOX (G). Nuclei were stained with DAPI (blue). Representative images (scale bar, 50 μm) and quantifications (n > 4 fields/lung) are shown. H and I, Tumor-free, 8- to 10-week-old SCID mice (n = 5–6 mice/group) were treated with PTX or vehicle control. After 72 hours, EMT6-GFP+ cells (25 × 104 cells/mouse) were injected through the tail vein to generate an ex vivo PuMA. After 15 minutes, lungs were perfused, excised, and sectioned. Lung sections were cultured for 1 week and analyzed by FluorVivo Mag system. Representative images are shown in H. Scale bar, 200 μm. The percentage of GFP+ cells in single-cell suspensions of lung sections was analyzed by flow cytometry (I). Statistical significance was assessed by one-way ANOVA followed by Tukey posttest when more than two groups were analyzed or unpaired two-tailed t test when only two groups were analyzed. Significant P values are shown as *, P < 0.05; **, P < 0.01; ***, P < 0.001 from control or otherwise indicated in the figure.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 5 from T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
Systemic LOX promotes ECM remodeling following PTX chemotherapy. Bone marrow cells were flushed from Cre+/−LOXflox/flox or their control counterpart Cre−/−LOXflox/flox mice. The bone marrow cells were then implanted into lethally irradiated wild-type BALB/c mice to generate a chimeric mouse model of inducible LOX depletion specifically in bone marrow cells. The chimeric mice (n = 6 mice/group) were treated with tamoxifen for 5 days, and PTX was administered on day 7. After 72 hours, mice were sacrificed and lungs and bone marrow were harvested. A, A schematic of the experimental procedure is presented. LOX levels in bone marrow cells were assessed by Western blot. B, Lung sections were stained with Sirius red to detect both collagen and elastin. Representative images are shown in two magnifications. Arrows, positive staining. Scale bar, 200 μm. Collagen and elastin levels were quantified by calculating the percentage of red pixels per field (n > 4 fields/lung). C–G, Tumor-free, 8- to 10-week-old SCID mice (n = 4–5 mice/group) were treated with PTX or vehicle control. After 72 hours, lungs were removed. Collagen and elastin in lung sections were detected by Sirius staining. Representative images in two magnifications are shown in C (scale bar, 200 μm), and quantification is shown in D. Lung sections were immunostained using antibodies against Collagen I (E), Collagen IV (F), and LOX (G). Nuclei were stained with DAPI (blue). Representative images (scale bar, 50 μm) and quantifications (n > 4 fields/lung) are shown. H and I, Tumor-free, 8- to 10-week-old SCID mice (n = 5–6 mice/group) were treated with PTX or vehicle control. After 72 hours, EMT6-GFP+ cells (25 × 104 cells/mouse) were injected through the tail vein to generate an ex vivo PuMA. After 15 minutes, lungs were perfused, excised, and sectioned. Lung sections were cultured for 1 week and analyzed by FluorVivo Mag system. Representative images are shown in H. Scale bar, 200 μm. The percentage of GFP+ cells in single-cell suspensions of lung sections was analyzed by flow cytometry (I). Statistical significance was assessed by one-way ANOVA followed by Tukey posttest when more than two groups were analyzed or unpaired two-tailed t test when only two groups were analyzed. Significant P values are shown as *, P < 0.05; **, P < 0.01; ***, P < 0.001 from control or otherwise indicated in the figure.